Cancer Communications
indexed by SCI
BMC

doi: 10.1186/s40880-015-0030-x
Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins
Meiqi Zeng, Manyin Zheng, Desheng Lu, Jun Wang, Wenqi Jiang and Ou Sha
School of Medicine, Shenzhen University Health Science Center, Shenzhen 518060, Guangdong, People’s Republic of China
[Abstract] Ribosome-inactivating proteins (RIPs) belong to a family of enzymes that attack eukaryotic ribosomes and potently inhibit cellular protein synthesis. RIPs possess several biomedical properties, including anti-viral and anti-tumor activities. Multiple RIPs are known to inhibit tumor cell proliferation through inducing apoptosis in a variety of cancers, such as breast cancer, leukemia/lymphoma, and hepatoma. This review focuses on the anti-tumor activities of RIPs and their apoptotic effects through three closely related pathways: mitochondrial, death receptor, and endoplasmic reticulum pathways.
Chinese Journal of Cancer 2015, Volume: 34, Issue 8
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)

[Google Scholar]


Cite this article

Meiqi Zeng, Manyin Zheng, Desheng Lu, Jun Wang, Wenqi Jiang and Ou Sha. Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins. Chin J Cancer. 2015, 34:30. doi:10.1186/s40880-015-0030-x


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China